Drug · DIN 02419610
POMALYST
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 31, 2025; first marketed February 24, 2014.
- Drug Identification Number (DIN)
- 02419610
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pomalidomide L04AX06
- Class
- Human
- Record last updated
- August 21, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| POMALIDOMIDE | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 25, 2024: NOC 32595New Drug Submission (NDS) · Administrative: Change in Product Ownership
- January 20, 2014: NOC 15139New Drug Submission (NDS)
Other DINs named POMALYST
- DIN 02419580 · Marketed
- DIN 02419599 · Marketed
- DIN 02419602 · Marketed